These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9645342)

  • 1. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis.
    Matsunaga T; Shirasawa H; Enomoto H; Yoshida H; Iwai J; Tanabe M; Kawamura K; Etoh T; Ohnuma N
    Int J Cancer; 1998 Jun; 79(3):226-31. PubMed ID: 9645342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
    Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
    Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
    Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
    Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
    Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
    Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B
    Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
    Tanaka T; Sugimoto T; Sawada T
    Cancer; 1998 Oct; 83(8):1626-33. PubMed ID: 9781958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
    Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
    Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
    Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
    Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
    Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of Trk-C in favourable human neuroblastomas.
    Yamashiro DJ; Liu XG; Lee CP; Nakagawara A; Ikegaki N; McGregor LM; Baylin SB; Brodeur GM
    Eur J Cancer; 1997 Oct; 33(12):2054-7. PubMed ID: 9516852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma.
    Terui E; Matsunaga T; Yoshida H; Kouchi K; Kuroda H; Hishiki T; Saito T; Yamada S; Shirasawa H; Ohnuma N
    Clin Cancer Res; 2005 May; 11(9):3280-7. PubMed ID: 15867224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage.
    Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S
    Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
    Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome.
    Hedborg F; Bjelfman C; Sparén P; Sandstedt B; Påhlman S
    Eur J Cancer; 1995; 31A(4):435-43. PubMed ID: 7576941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.